000144608 001__ 144608
000144608 005__ 20240229112631.0
000144608 0247_ $$2doi$$a10.1038/s41375-019-0395-y
000144608 0247_ $$2pmid$$apmid:30728457
000144608 0247_ $$2ISSN$$a0887-6924
000144608 0247_ $$2ISSN$$a1476-5551
000144608 0247_ $$2altmetric$$aaltmetric:55169906
000144608 037__ $$aDKFZ-2019-02050
000144608 041__ $$aeng
000144608 082__ $$a610
000144608 1001_ $$0P:(DE-HGF)0$$aSchlenk, R. F.$$b0$$eFirst author
000144608 245__ $$aRandomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine.
000144608 260__ $$aLondon$$bSpringer Nature$$c2019
000144608 3367_ $$2DRIVER$$aarticle
000144608 3367_ $$2DataCite$$aOutput Types/Journal article
000144608 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1566567021_407
000144608 3367_ $$2BibTeX$$aARTICLE
000144608 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000144608 3367_ $$00$$2EndNote$$aJournal Article
000144608 520__ $$aRandomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine.
000144608 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000144608 588__ $$aDataset connected to CrossRef, PubMed,
000144608 7001_ $$aWeber, D.$$b1
000144608 7001_ $$aHerr, W.$$b2
000144608 7001_ $$aWulf, G.$$b3
000144608 7001_ $$aSalih, H. R.$$b4
000144608 7001_ $$aDerigs, H. G.$$b5
000144608 7001_ $$aKuendgen, A.$$b6
000144608 7001_ $$aRinghoffer, M.$$b7
000144608 7001_ $$aHertenstein, B.$$b8
000144608 7001_ $$aMartens, U. M.$$b9
000144608 7001_ $$aGrießhammer, M.$$b10
000144608 7001_ $$aBernhard, H.$$b11
000144608 7001_ $$aKrauter, J.$$b12
000144608 7001_ $$aGirschikofsky, M.$$b13
000144608 7001_ $$aWolf, D.$$b14
000144608 7001_ $$aLange, E.$$b15
000144608 7001_ $$aWestermann, J.$$b16
000144608 7001_ $$aKoller, E.$$b17
000144608 7001_ $$aKremers, S.$$b18
000144608 7001_ $$aWattad, M.$$b19
000144608 7001_ $$aHeuser, M.$$b20
000144608 7001_ $$aThol, F.$$b21
000144608 7001_ $$aGöhring, G.$$b22
000144608 7001_ $$aHaase, D.$$b23
000144608 7001_ $$aTeleanu, V.$$b24
000144608 7001_ $$aGaidzik, V.$$b25
000144608 7001_ $$0P:(DE-He78)e15dfa1260625c69d6690a197392a994$$aBenner, A.$$b26$$udkfz
000144608 7001_ $$aDöhner, K.$$b27
000144608 7001_ $$aGanser, A.$$b28
000144608 7001_ $$aPaschka, P.$$b29
000144608 7001_ $$aDöhner, H.$$b30
000144608 773__ $$0PERI:(DE-600)2008023-2$$a10.1038/s41375-019-0395-y$$gVol. 33, no. 8, p. 1923 - 1933$$n8$$p1923 - 1933$$tLeukemia$$v33$$x1476-5551$$y2019
000144608 909CO $$ooai:inrepo02.dkfz.de:144608$$pVDB
000144608 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000144608 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e15dfa1260625c69d6690a197392a994$$aDeutsches Krebsforschungszentrum$$b26$$kDKFZ
000144608 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000144608 9141_ $$y2019
000144608 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000144608 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000144608 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bLEUKEMIA : 2017
000144608 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000144608 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000144608 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000144608 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000144608 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000144608 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000144608 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000144608 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000144608 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000144608 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bLEUKEMIA : 2017
000144608 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lBiostatistik$$x0
000144608 980__ $$ajournal
000144608 980__ $$aVDB
000144608 980__ $$aI:(DE-He78)C060-20160331
000144608 980__ $$aUNRESTRICTED